Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,803 | 161 | 96.7% |
| Education | $228.64 | 9 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $906.66 | 21 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $729.78 | 21 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $677.98 | 11 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $497.90 | 5 | $0 (2019) |
| Janssen Biotech, Inc. | $477.73 | 10 | $0 (2020) |
| Celgene Corporation | $444.88 | 7 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $370.98 | 11 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $362.17 | 4 | $0 (2019) |
| PFIZER INC. | $343.68 | 11 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $244.24 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $81.90 | 1 | AstraZeneca Pharmaceuticals LP ($81.90) |
| 2020 | $326.66 | 5 | AstraZeneca Pharmaceuticals LP ($189.39) |
| 2019 | $1,955 | 22 | Novartis Pharmaceuticals Corporation ($252.36) |
| 2018 | $1,536 | 29 | AstraZeneca Pharmaceuticals LP ($289.93) |
| 2017 | $3,133 | 113 | Genentech USA, Inc. ($775.41) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $81.90 | General |
| Category: Oncology | ||||||
| 03/05/2020 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $35.33 | General |
| Category: Oncology | ||||||
| 02/25/2020 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $81.60 | General |
| Category: Oncology | ||||||
| 02/07/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $101.94 | General |
| Category: HEMATOLOGY | ||||||
| 02/05/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $105.67 | General |
| 01/09/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $2.12 | General |
| 12/08/2019 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $118.81 | General |
| Category: Hepatology | ||||||
| 12/07/2019 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $122.15 | General |
| Category: Hepatology | ||||||
| 10/16/2019 | Medtronic USA, Inc. | OSTEOCOOL RF ABLATION (Device) | Food and Beverage | In-kind items and services | $102.40 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 10/10/2019 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: Oncology | ||||||
| 08/21/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $116.04 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2019 | Genentech USA, Inc. | Rituxan (Biological), GAZYVA, VENCLEXTA | Food and Beverage | In-kind items and services | $131.25 | General |
| Category: BioOncology/Immunology | ||||||
| 06/26/2019 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug) | Food and Beverage | In-kind items and services | $120.85 | General |
| Category: HEMATOLOGY | ||||||
| 06/12/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $117.04 | General |
| Category: ONCOLOGY | ||||||
| 06/10/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $118.78 | General |
| 05/21/2019 | PFIZER INC. | MYLOTARG (Biological), BOSULIF, BESPONSA | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 05/09/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $104.02 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Oncology | ||||||
| 04/30/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $86.89 | General |
| Category: Oncology | ||||||
| 04/18/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $113.95 | General |
| Category: Oncology | ||||||
| 04/10/2019 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $112.09 | General |
| Category: ONC | ||||||
| 04/08/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 03/27/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $117.17 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 11 | 442 | 2,255 | $222,645 | $84,241 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 238 | 669 | $133,800 | $50,542 | 37.8% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2020 | 19 | 1,310 | $36,680 | $9,444 | 25.7% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2020 | 11 | 59 | $9,440 | $9,360 | 99.2% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 33 | 38 | $15,010 | $4,336 | 28.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 20 | 21 | $8,400 | $3,447 | 41.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 14 | 14 | $5,460 | $2,182 | 40.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 35 | $4,725 | $2,047 | 43.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 18 | $2,700 | $1,087 | 40.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 15 | 16 | $2,400 | $924.96 | 38.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 43 | 56 | $3,080 | $618.21 | 20.1% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2020 | 15 | 19 | $950.00 | $252.92 | 26.6% |
About Dr. Ghulam Qureshi, M.D
Dr. Ghulam Qureshi, M.D is a Hematology & Oncology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245201045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ghulam Qureshi, M.D has received a total of $7,032 in payments from pharmaceutical and medical device companies, with $81.90 received in 2023. These payments were reported across 170 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,803).
As a Medicare-enrolled provider, Qureshi has provided services to 442 Medicare beneficiaries, totaling 2,255 services with total Medicare billing of $84,241. Data is available for 1 year (2020–2020), covering 11 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Specialist
- Location Richmond, VA
- Active Since 01/30/2006
- Last Updated 09/25/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1245201045
Products in Payments
- NINLARO (Drug) $492.73
- IMBRUVICA (Drug) $436.12
- Avastin (Biological) $293.30
- Imbruvica (Drug) $244.24
- SOLIRIS (Drug) $243.39
- IMFINZI (Drug) $241.36
- Doptelet (Drug) $240.96
- KEYTRUDA (Biological) $235.70
- TAGRISSO (Drug) $223.60
- RYDAPT (Drug) $209.94
- Yescarta (Drug) $204.83
- Rituxan (Biological) $192.59
- PROMACTA (Drug) $190.23
- INJECTAFER (Drug) $175.99
- OPDIVO (Biological) $161.62
- Revlimid (Drug) $158.88
- XTANDI (Drug) $158.10
- Abraxane (Drug) $138.74
- TECENTRIQ (Biological) $121.91
- TASIGNA (Drug) $121.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Richmond
Dr. Victor Yazbeck, M.d, M.D
Hematology & Oncology — Payments: $390,374
Attique Samdani, M.d, M.D
Hematology & Oncology — Payments: $146,382
Dr. Elke Friedman, Md, MD
Hematology & Oncology — Payments: $25,274
Dr. Asit Paul, M.d., Ph.d.,, M.D., PH.D.,
Hematology & Oncology — Payments: $7,490
Gisa-Beate Schunn, M.d, M.D
Hematology & Oncology — Payments: $5,929
Erin Alesi, Md, MD
Hematology & Oncology — Payments: $5,636